BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 2
• 3
• 4
• 5
• 6
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30
• 31

• Biotech Beach

  Organovo Presents New Preclinical Data on 3D Bioprinted Human Liver Tissues for the Treatment of Inborn Errors of Metabolism at The Liver Meeting 2017 (AASLD)

  This data will be presented by Vaidehi Joshi, Scientist I, Therapeutics, at Organovo.

  October 20, 2017

   · 

  7 min read
• 

  Job Trends

  Merck to Cut 1,800 Jobs and Add 960 in Chronic Care

  The particular areas where sales jobs will be thinned are primary care, disease-focused endocrinology and hospital chronic care.

  October 20, 2017

   · 

  2 min read

   · 

  Mark Terry
• Deals

  GIMDx/Improve Medical Gain China Rights to PD-L1 Quantifying Assay

  GIMDx of Carlsbad, California acquired exclusive China OEM and distribution rights to oncology diagnostic products made by IncellDx, a Menlo Park company.

  October 20, 2017

   · 

  1 min read
• Biotech Beach

  ACEA Biosciences Release: Characterizing Bacteriophage-Derived Enzymes That Degrade Staphylococcus Biofilms

  Biofilms are surface-attached communities of bacterial or fungal cells that are enmeshed in an extensive extracellular matrix which makes them more resistant to both antibiotics and the immune system.

  October 20, 2017

   · 

  4 min read
• Medeon Biodesign Announces Successful Clinical Use of AbClose Laparoscopic Port Site Closure Device in the United States

  Medeon Biodesign is pleased to announce that its innovative laparoscopic port site closure device, AbClose, successfully closed more than 50 wounds in a variety of laparoscopic surgeries.

  October 20, 2017

   · 

  3 min read
• Pharm Country

  Bristol-Myers Squibb to Present New Data Advancing Research Across Serious Liver Diseases At The Liver Meeting 2017

  Bristol-Myers Squibb Company today announced that new data across serious liver diseases, including nonalcoholic steatohepatitis (NASH) and hepatocellular carcinoma (HCC), will be presented at The Liver Meeting 2017 in Washington, DC, October 20 - 24, 2017.

  October 20, 2017

   · 

  37 min read
• Drug Development

  Omeros Reports Successful OMS721 Treatment of Patient With Both Stem Cell Transplant-Associated Thrombotic Microangiopathy and Graft-Versus-Host Disease

  The results may expand target for Omeros’ planned phase 3 program in HCT-TMA.

  October 20, 2017

   · 

  11 min read
• Drug Development

  Aurinia to Expand Renal Franchise With Novel Indications and Launches Development Program for Treatment of Dry Eye Syndrome

  Aurinia Pharmaceuticals announced plans to expand its voclosoprin renal franchise to include focal segmental glomerulosclerosis (FSGS) and minimal change disease (MCD).

  October 20, 2017

   · 

  10 min read
• Mergenet Solutions Issues Dividend

  Mergenet Solutions of Coconut Creek, FL has declared a cash dividend.

  October 20, 2017

   · 

  1 min read
• Drug Development

  Gilead Announces Multiple Scientific Presentations Demonstrating High Cure Rates in Difficult-to-Cure HCV Patients and Improved Long-Term Bone and Renal Safety of Vemlidy in HBV Patients Switched From Viread

  Gilead Sciences, Inc.today announced results from Phase II and Phase III studies of its approved medicines for chronic hepatitis C virus (HCV) and hepatitis B virus (HBV) infection.

  October 20, 2017

   · 

  15 min read